To include your compound in the COVID-19 Resource Center, submit it here.
INDICATION: Colorectal cancer
Mouse studies suggest inhibiting the metabolic enzymes ketohexokinase, NADK or SUCLA2 could help treat KRAS-mutant colorectal
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury